Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Nature Communications|March 31, 2015
The nuclear translocation of ERK1/2 as an anticancer targetAlexander Plotnikov, Karen Flores, Galia Maik-Rachline, et al.
Plos One|March 14, 2013
Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studiesMichal J Besser, Tsipi Shoham, Orit Harari-Steinberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 6, 2016
Membrane-attached Cytokines Expressed by mRNA Electroporation Act as Potent T-Cell AdjuvantsHadas Weinstein-Marom, Aviad Pato, Noam Levin, et al.
Anticancer Research|September 15, 2019
Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic MelanomaDouglas Zippel, Orli Friedman-Eldar, Shlomi Rayman, et al.
Oncotarget|December 17, 2017
Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanomaGilli Galore-Haskel, Erez N Baruch, Amy L Berg, et al.
Oncoimmunology|November 20, 2019
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapySharon Yunger, Assaf Bar El, Li-At Zeltzer, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2020
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapyGilli Galore-Haskel, Eyal Greenberg, Inbal Yahav, et al.
The Israel Medical Association Journal : IMAJ|April 8, 2006
Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical CenterMichal J Besser, Avraham J Treves, Orit Itzhaki, et al.
Plos One|May 15, 2009
Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cellsGal Markel, Rachel Seidman, Michal J Besser, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2012
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, et al.
Pageof 8